Angel ® Catheter use for pulmonary embolism prophylaxis in a polytrauma patient

Prophylactic use of the Angel® Catheter in a patient with paraneoplastic syndrome scheduled for surgical tumor resection: A case report and literature review

“…Because the Angel ® catheter could help avoid the traditional IVC filter complications, such as the vena cava perforation, filter tilting, filter migration, and irretrievability, the Angel ® catheter use seems reasonable and deserves further investigation. The Angel ® catheter use could also be reasonable in the patients who need postoperative LMWH prophylaxis discontinued because of bleeding or other concerns 1 . In this report, we used the IVC filter-catheter because the patient was at a risk for postoperative bleeding complications, including gastrointestinal bleeding and postoperative bleeding and was also at risk for PE due to known DVT.…”

“…The Angel ® catheter (BiO2 Medical Inc, San Antonio, Texas, USA) is a novel device that combines the inferior vena cava (IVC) filter with triple lumen central venous catheter (IVC filter-catheter). It is used as a temporary IVC filter for pulmonary embolism (PE) prevention and also provides central venous access in the critically ill patients where the routine PE prophylaxis methods, such as anticoagulation, or mechanical compression devices, are contraindicated 1,2 . The Angel ® catheter received United States Food and Drug Administration (FDA) approval for clinical investigation use in the United States in 2013, followed by FDA 510(k) clearance in 2016 as a medical device for protection of critically ill patients at a high PE risk when anticoagulation is contraindicated 3 .…”

“…The Angel ® catheter advantages include less invasive placement and the convenience of bedside placement, thereby eliminating the need to transport patients to radiology, which can cause delays and increase deep venous thrombosis (DVT) and a PE risk 1 . Published data suggest that the Angel ® catheter is safe and effective for short-term PE prophylaxis in the high risk patients with contraindications to anticoagulation 14 .…”

“…Published data suggest that the Angel ® catheter is safe and effective for short-term PE prophylaxis in the high risk patients with contraindications to anticoagulation 14 . The Angel ® catheter placement may also bring benefit to the patients with major trauma, intracerebral hemorrhage, stroke, venous thromboembolic events or active bleeding 1,14 .…”

Venous Thromboembolism in Trauma: The Role of Anticoagulation and Inferior Vena Cava Filters

“…A few small studies have shown favorable safety profiles and efficacy in preventing PE. [45][46][47][48] A number of PE risk scoring systems have been developed in trauma patients which may help stratify patients into high-risk groups that may benefit more from a prophylactic IVCF. [49][50][51] No previous studies have included a predictive scoring system when deciding which patients should receive prophylactic IVCF, and an interesting area of future research may be to incorporate such a scoring system to identify a subgroup of patients who have significantly increased benefit to IVCF placement.…”